Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Retinoids and apoptosis: implications for cancer chemoprevention and therapy.

× No keyword cloud information.

28 in total

Review 1. Chemopreventive potential of natural compounds in head and neck cancer.

Authors: Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal: Nutr Cancer Date: 2010 Impact factor: 2.900

2. The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.

Authors: Numsen Hail; Ping Chen; Michael F Wempe
Journal: Free Radic Biol Med Date: 2010-10-23 Impact factor: 7.376

Review 3. Retinoid pathway and cancer therapeutics.

Authors: Nathan Bushue; Yu-Jui Yvonne Wan
Journal: Adv Drug Deliv Rev Date: 2010-08-03 Impact factor: 15.470

4. Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.

Authors: Ruta D Rao; Melody A Cobleigh; Robert Gray; Mark L Graham; Larry Norton; Silvana Martino; George Thomas Budd; James N Ingle; William C Wood
Journal: Med Oncol Date: 2010-09-28 Impact factor: 3.064

Retinoids and apoptosis: implications for cancer chemoprevention and therapy.

Review 1. Chemopreventive potential of natural compounds in head and neck cancer.

2. The hydroxyl functional group of N-(4-hydroxyphenyl)retinamide mediates cellular uptake and cytotoxicity in premalignant and malignant human epithelial cells.

Review 3. Retinoid pathway and cancer therapeutics.

4. Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group.

Review 5. Chemoprevention of breast cancer with fenretinide.

Review 6. Retinol as electron carrier in redox signaling, a new frontier in vitamin A research.

7. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).

8. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.

9. Role for PKC δ in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells.

10. Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potential.